Counterpoint Mutual Funds LLC Takes Position in Pediatrix Medical Group, Inc. (NYSE:MD)

Counterpoint Mutual Funds LLC purchased a new position in Pediatrix Medical Group, Inc. (NYSE:MD - Free Report) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm purchased 28,717 shares of the company's stock, valued at approximately $377,000.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the business. Pacer Advisors Inc. purchased a new position in shares of Pediatrix Medical Group in the 4th quarter worth $35,492,000. Weiss Asset Management LP raised its holdings in shares of Pediatrix Medical Group by 50.5% in the 3rd quarter. Weiss Asset Management LP now owns 912,818 shares of the company's stock worth $10,580,000 after purchasing an additional 306,143 shares during the period. Raymond James Financial Inc. acquired a new position in shares of Pediatrix Medical Group in the 4th quarter valued at about $3,066,000. RBF Capital LLC purchased a new stake in shares of Pediatrix Medical Group during the 3rd quarter worth about $1,695,000. Finally, Rubric Capital Management LP grew its holdings in shares of Pediatrix Medical Group by 1.5% during the 3rd quarter. Rubric Capital Management LP now owns 8,275,000 shares of the company's stock worth $95,907,000 after purchasing an additional 125,000 shares during the period. Hedge funds and other institutional investors own 97.71% of the company's stock.

Pediatrix Medical Group Stock Up 0.2 %

MD stock traded up $0.03 during trading on Friday, reaching $14.18. The stock had a trading volume of 2,623,334 shares, compared to its average volume of 639,797. The company has a current ratio of 1.60, a quick ratio of 1.42 and a debt-to-equity ratio of 0.81. The firm has a fifty day moving average price of $14.28 and a 200 day moving average price of $13.49. The company has a market capitalization of $1.22 billion, a P/E ratio of -11.81, a PEG ratio of 1.74 and a beta of 1.49. Pediatrix Medical Group, Inc. has a 1-year low of $6.62 and a 1-year high of $17.67.

Remove Ads

Pediatrix Medical Group (NYSE:MD - Get Free Report) last released its quarterly earnings results on Thursday, February 20th. The company reported $0.49 EPS for the quarter, topping the consensus estimate of $0.37 by $0.12. Pediatrix Medical Group had a positive return on equity of 15.47% and a negative net margin of 4.92%. The business had revenue of $502.36 million for the quarter, compared to analysts' expectations of $486.22 million. On average, equities analysts anticipate that Pediatrix Medical Group, Inc. will post 1.38 earnings per share for the current year.

Wall Street Analyst Weigh In

Several equities research analysts have issued reports on the stock. Truist Financial boosted their price objective on shares of Pediatrix Medical Group from $15.00 to $18.00 and gave the stock a "hold" rating in a research note on Friday, February 21st. UBS Group upped their price target on shares of Pediatrix Medical Group from $16.50 to $18.50 and gave the stock a "neutral" rating in a research report on Friday, February 21st. Macquarie assumed coverage on Pediatrix Medical Group in a research report on Monday, December 16th. They issued an "outperform" rating and a $18.00 price objective on the stock. Finally, StockNews.com raised Pediatrix Medical Group from a "hold" rating to a "buy" rating in a research report on Wednesday, January 22nd. Four equities research analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, Pediatrix Medical Group has a consensus rating of "Hold" and a consensus price target of $17.08.

Pediatrix Medical Group Company Profile

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.